C07K 14/4712
Cystic fibrosis
Official title: {Cystic fibrosis}
C07K14/4712 (Cystic fibrosis) appears on 162 US grants and 154 published applications in this corpus.
Search patents in C07K- Granted patents
- 162
- Published applications
- 154
- Assignees
- 102
- Inventors
- 383
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 7 | 0 |
| 1998 | 12 | 0 |
| 1999 | 21 | 0 |
| 2000 | 15 | 0 |
| 2001 | 6 | 2 |
| 2002 | 8 | 14 |
| 2003 | 6 | 12 |
| 2004 | 4 | 6 |
| 2005 | 5 | 7 |
| 2006 | 4 | 5 |
| 2007 | 5 | 2 |
| 2008 | 1 | 2 |
| 2009 | 1 | 7 |
| 2010 | 2 | 4 |
| 2011 | 2 | 4 |
| 2012 | 3 | 2 |
| 2013 | 3 | 6 |
| 2014 | 7 | 4 |
| 2015 | 3 | 5 |
| 2016 | 2 | 7 |
| 2017 | 3 | 4 |
| 2018 | 2 | 5 |
| 2019 | 2 | 5 |
| 2020 | 4 | 6 |
| 2021 | 2 | 7 |
| 2022 | 5 | 8 |
| 2023 | 7 | 9 |
| 2024 | 1 | 10 |
| 2025 | 4 | 7 |
| 2026 | 6 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTR11 Aug 2026US 12,702,693 B2Translate Bio, Inc.
- Compositions and methods for the treatment of cystic fibrosis11 Aug 2026US 12,703,726 B2University of Iowa Research Foundation
- RNA preparations comprising purified modified RNA for reprogramming cells16 Jun 2026US 12,655,395 B2
- Compositions for CFTR MRNA therapy21 Apr 2026US 12,605,399 B2Translate Bio, Inc.
- CFTR mRNA compositions and related methods and uses7 Apr 2026US 12,594,295 B2ethris GmbH
- Rna preparations comprising purified modified rna for reprogramming cells1 Oct 2026US 2026/0297538 A1The Trustees of the University of Pennsylvania
- Recombinant adeno-associated viral vector for gene delivery3 Sep 2026US 2026/0258445 A1Abeona Therapeutics Inc.
- Compositions and Methods for Delivering CFTR Polypeptides30 Apr 2026US 2026/0116934 A1Krystal Biotech, Inc.
- Compositions and methods for virotherapy26 Feb 2026US 2026/0053948 A1Yeda Research and Development Co. Ltd.
- Compositions, methods and uses for treating cystic fibrosis and related disorders11 Sep 2025US 2025/0281580 A1Board of Regents, The University of Texas System
Most cited
By later US patents
- RNA containing modified nucleosides and methods of use thereof353US 8,278,036 B2The Trustees of the University of Pennsylvania · 2012
- Hybrid adenovirus-AAV virus and methods of use thereof311US 5,871,982 AThe Trustees of the University of Pennsylvania · 1999
- Adenovirus vectors for gene therapy278US 5,585,362 AThe Regents of the University of Michigan · 1996
- RNA containing modified nucleosides and methods of use thereof230US 8,691,966 B2The Trustees of the University of Pennsylvania · 2014
- Gene therapy vector for cystic fibrosis226US 5,240,846 AThe Regents of the University of Michigan · 1993